TY  - JOUR
AU  - Almendro-Delia, Manuel
AU  - Blanco-Ponce, Emilia
AU  - Carmona-Carmona, Jesus
AU  - Arboleda-Sanchez, J A
AU  - Rodriguez-Yañez, Juan Carlos
AU  - Soto-Blanco, Jose Manuel
AU  - Fernandez-Garcia, Isabel
AU  - Castillo-Caballero, Jose M
AU  - Garcia-Rubira, Juan C
AU  - Hidalgo-Urbano, Rafael J
PY  - 2022
DO  - 10.3389/fcvm.2022.887748
SN  - 2297-055X
UR  - http://hdl.handle.net/10668/20550
T2  - Frontiers in cardiovascular medicine
AB  - The net clinical benefit of ticagrelor over clopidogrel in acute coronary syndrome (ACS) has recently been questioned by observational studies which did not account for time-dependent confounders. We aimed to assess the comparative safety and...
LA  - en
PB  - Frontiers Research Foundation
KW  - P2Y 12 inhibitor
KW  - Acute coronary syndrome
KW  - Dual antiplatelet therapy
KW  - Exposure misclassification
KW  - Medication adherence
KW  - Clopidogrel
KW  - Acute Coronary Syndrome
KW  - Patient Discharge
KW  - Intention to Treat Analysis
KW  - ST Elevation Myocardial Infarction
TI  - Comparative Safety and Effectiveness of Ticagrelor versus Clopidogrel in Patients With Acute Coronary Syndrome: An On-Treatment Analysis From a Multicenter Registry.
TY  - research article
VL  - 9
ER  -